Letter to the Editor. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F05%3A00000479" target="_blank" >RIV/00023752:_____/05:00000479 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Letter to the Editor. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride

Original language description

Hyperprolactinaemia is an important but neglected adverse effect of antipsychotic medication. It occurs frequently with conventional antipsychotics and some atypical antipsychotics (risperidone and amisulpride). We found hyperprolactinaemia in all 10 patients evaluated during therapy with low doses (50 mg per day) of amisulpride used as an augmentation to antidepressant treatment, benzodiazepines or in monotherapy. We decided to suspend amisulpride treatment for patients in which no clinical benefits were observed.

Czech name

Dopis redaktorovi. Normalizace hyperprolaktinemie po vysazení nízkých dávek amilsulpridu

Czech description

Autoři popisují normalizaci hyperprolaktinemie po vysazení amilsurpridu u 5 pacientů.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FL - Psychiatry, sexology

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2005

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Neuroendocrinology Letters

ISSN

0172-780X

e-ISSN

—

Volume of the periodical

26

Issue of the periodical within the volume

4

Country of publishing house

SE - SWEDEN

Number of pages

1

Pages from-to

320

UT code for WoS article

—

EID of the result in the Scopus database

—